Cancer prevention is no longer just a personal battle—it’s a political imperative. And this is where the game changes. The European Public Health Alliance (EPHA) enthusiastically welcomes the 5th edition of the European Code Against Cancer (ECAC5), a groundbreaking update that shifts the focus from individual responsibility to collective, systemic action. But here’s where it gets controversial: can governments truly prioritize public health over commercial interests? Let’s dive in.
After over a decade, the European Code Against Cancer has been revamped, and its timing couldn’t be more critical. Cancer remains a leading cause of premature death in Europe, and preventable risk factors are still deeply embedded in our daily lives. ECAC5 (https://cancer-code-europe.iarc.who.int/) isn’t just an update—it’s a paradigm shift. For the first time, it explicitly frames cancer prevention as a shared societal and political duty, not just a matter of personal choice.
EPHA applauds ECAC5 (https://www.iarc.who.int/news-events/reducing-cancer-risk-through-science-the-evidence-base-behind-the-european-code-against-cancer-5th-edition-described-in-two-new-publications) for its bold approach. It doesn’t just refresh the science behind cancer prevention; it challenges policymakers to step up. The Code now speaks directly to those in power, acknowledging that individual choices are shaped—and often limited—by policy decisions, commercial influences, and environmental factors. This isn’t just advice; it’s a call to accountability.
What’s new in ECAC5? While previous editions (https://www.sciencedirect.com/science/article/pii/S1877782115001277) focused on individual actions, ECAC5 expands its scope. It retains the core recommendations, increasing them from 12 to 14, but introduces a parallel set of guidelines for policymakers (https://cancer-code-europe.iarc.who.int/wp-content/uploads/2025/10/European-Code-Against-Cancer-5th-edition.pdf). These emphasize the need for structural changes: regulation, fiscal measures, public investment, and protection from harmful commercial practices. This marks a decisive break from the outdated belief that awareness and behavior change alone can prevent cancer.
The updated recommendations reflect today’s complex risk landscape. They address vaping and emerging nicotine products, reinforce the call to avoid alcohol entirely, strengthen guidance on diet, obesity, and ultra-processed foods, and expand HPV vaccination to all genders. Critically, ECAC5 also highlights environmental risk factors, updating advice on radon, sun exposure, and occupational carcinogens. It introduces a new recommendation on reducing air pollution—a leading cancer risk—emphasizing the role of governments in this effort.
A win-win for cancer prevention and beyond. One of ECAC5’s standout features is its alignment with the prevention of other noncommunicable diseases (NCDs). By targeting shared risk factors like tobacco use, alcohol consumption, unhealthy diets, physical inactivity, and environmental exposures, it reinforces integrated NCD prevention efforts. This maximizes health gains and optimizes public resources, complementing initiatives like WHO’s “best buys” (https://www.who.int/news/item/26-05-2023-more-ways--to-save-more-lives--for-less-money----world-health-assembly-adopts-more-best-buys--to-tackle-noncommunicable-diseases) and the EU’s Safe Hearts Plan (https://epha.org/framing-action-for-cardiovascular-health-in-europe-reflections-on-the-new-eu-safe-hearts-plan/).
The real breakthrough: policy recommendations. From EPHA’s perspective, the policy recommendations are the most transformative aspect of ECAC5. They translate scientific consensus into actionable expectations for governments: regulate harmful products, curb aggressive marketing, ensure clean air and safe workplaces, invest in vaccination and screening, and design health-promoting food, transport, and urban systems. But here’s the controversial part: can governments resist commercial pressures to implement these measures effectively?
ECAC5 also tackles equity and integrity. It recognizes that cancer risk is socially patterned and that prevention policies must reduce health inequalities, not worsen them. It underscores the need to shield public health policy from commercial interference, a critical step for effective regulation in areas like tobacco, alcohol, and ultra-processed foods. In doing so, ECAC5 shifts the focus from individual blame to public accountability, making it clear that failing to prevent cancer is a political failure, not just a personal one.
From evidence to action: the role of civil society. EPHA is proud to have contributed to ECAC5’s development (https://www.sciencedirect.com/science/article/pii/S2666776226000049), with its Director General participating in the expert work led by IARC. This highlights the vital role of independent public health and civil society voices in shaping credible, evidence-based guidance. We echo the European Cancer League’s stance (https://www.cancer.eu/european-code-against-cancer/): ECAC5 must be a practical policy tool, not just a communication instrument. Its success will be measured by concrete actions at the EU, national, and local levels, not by downloads or endorsements.
From code to action. ECAC5 delivers a clear message: cancer prevention cannot be left to individuals alone. It demands political leadership, regulatory courage, and sustained public investment. As Europe debates its health priorities, the Code offers a scientifically robust and politically relevant roadmap for prevention that benefits not just cancer outcomes, but overall population health. It leaves policymakers with fewer excuses—and a clearer responsibility—to act.
Now, we ask you: Do you think governments can rise to the challenge of implementing ECAC5’s recommendations, or will commercial interests continue to hinder progress? Share your thoughts in the comments below!
